BRIM Biotechnology, Inc. (6885.TWO)
TWD 37.6
(0.0%)
TWD 37.6
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.77 Billion TWD | 89.22% |
| 2022 | 939.99 Million TWD | 89.73% |
| 2021 | 495.43 Million TWD | 56.15% |
| 2020 | 317.28 Million TWD | -28.83% |
| 2019 | 445.78 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.73 Billion TWD | -2.32% |
| 2024 Q2 | 1.64 Billion TWD | -5.59% |
| 2023 Q4 | 1.77 Billion TWD | 0.0% |
| 2023 Q2 | 781.21 Million TWD | 0.0% |
| 2023 Q1 | - TWD | -100.0% |
| 2023 FY | 1.77 Billion TWD | 89.22% |
| 2023 Q3 | 1.77 Billion TWD | 127.68% |
| 2022 Q3 | 939.99 Million TWD | 0.0% |
| 2022 Q4 | 939.99 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -1289.077% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 38.685% |
| Level Biotechnology Inc. | 822.67 Million TWD | -116.206% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -167.581% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -224.133% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 54.322% |
| GlycoNex Incorporation | 1.55 Billion TWD | -14.545% |
| VBI | 452.1 Million TWD | -293.423% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -51.229% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -137.609% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -370.098% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -56.871% |
| Visgeneer Inc. | 397.17 Million TWD | -347.829% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 52.825% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 17.617% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -101.413% |
| Neith Corporation | 192.15 Million TWD | -825.654% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 70.806% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -2318.052% |
| Enimmune corporation | 604.82 Million TWD | -194.079% |
| TaiRx, Inc. | 833.74 Million TWD | -113.335% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 42.364% |
| EirGenix Inc. | 11.16 Billion TWD | 84.066% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -210.339% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -3.872% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 50.547% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -69.32% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -490.858% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -572.066% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -303.152% |
| RBC Bioscience Corporation | 753.79 Million TWD | -135.964% |
| BiOptic Inc. | 613.77 Million TWD | -189.793% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -53.371% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -175.828% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 42.739% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1102.341% |
| NaviFUS Corp. | 490.53 Million TWD | -262.598% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -45.113% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -30.461% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -236.14% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -53.151% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -7.39% |
| AP Biosciences Inc | 890.75 Million TWD | -99.681% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 79.141% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -448.722% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -33.369% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 34.392% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 88.423% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -333.549% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -348.196% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 14.319% |
| TCI GENE Inc. | 1.16 Billion TWD | -52.553% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -503.797% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -30.465% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -88.866% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -154.659% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 55.015% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 53.47% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -44.626% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 68.26% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -67.482% |
| Acepodia, Inc. | 6.81 Billion TWD | 73.914% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 53.517% |